{"filing":{"accession_number":"0001213900-26-075528","cik":"0001723980","ticker":"SXTC","company_name":"China SXT Pharmaceuticals, Inc.","form":"6-K","filing_date":"2026-07-06","report_date":null,"primary_document":"ea0296876-6k_chinasxt.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1723980/000121390026075528/ea0296876-6k_chinasxt.htm"},"events":[{"id":16223,"run_id":14477,"accession_number":"0001213900-26-075528","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"The 6-K discloses entry into a Securities Purchase Agreement on July 3, 2026, under which China SXT Pharmaceuticals agreed to issue Class A ordinary shares to an institutional investor for up to $30 million in aggregate, with an initial closing of $3.15 million expected July 6, 2026. The securities were issued in reliance on Regulation D (private placement exemption), not registered under the Securities Act. This is a dilutive equity issuance characteristic of a PIPE or private placement, material to investors assessing ownership dilution and capital structure.","company_name":"China SXT Pharmaceuticals, Inc.","ticker":"SXTC","filing_date":"2026-07-06","form":"6-K","submitted_at":null,"items":null}],"classifications":[{"id":14263,"accession_number":"0001213900-26-075528","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"reasoning":"The 6-K discloses entry into a Securities Purchase Agreement on July 3, 2026, under which China SXT Pharmaceuticals agreed to issue Class A ordinary shares to an institutional investor for up to $30 million in aggregate, with an initial closing of $3.15 million expected July 6, 2026. The securities were issued in reliance on Regulation D (private placement exemption), not registered under the Securities Act. This is a dilutive equity issuance characteristic of a PIPE or private placement, material to investors assessing ownership dilution and capital structure.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-07-07T18:53:57.525601+00:00","company_name":"China SXT Pharmaceuticals, Inc.","ticker":"SXTC","filing_date":"2026-07-06"}]}